EP Patent

EP1810970A1 — Therapeutic piperazine compounds

Assigned to Euro Celtique SA · Expires 2007-07-25 · 19y expired

What this patent protects

The present invention relates to Hydroxyiminopiperazine Compounds for use and treating or preventing a condition treatable or preventable by inhibiting VR 1 , and compositions comprising an effective amount of Hydroxyiminopiperzine Compound.

USPTO Abstract

The present invention relates to Hydroxyiminopiperazine Compounds for use and treating or preventing a condition treatable or preventable by inhibiting VR 1 , and compositions comprising an effective amount of Hydroxyiminopiperzine Compound.

Drugs covered by this patent

Patent Metadata

Patent number: EP1810970A1
Jurisdiction: EP
Classification: —
Expires: 2007-07-25
Drug substance claim: No
Drug product claim: No
Assignee: Euro Celtique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.